SWOBYSwedish Orphan Biovitrum AB

About Swedish Orphan Biovitrum AB (SWOBY)

Swedish Orphan Biovitrum AB (SWOBY) is a Drug Manufacturers - Specialty & Generic company headquartered in Stockholm, Sweden whose shares trade over-the-counter on the Pink tier.

Swedish Orphan Biovitrum AB, an integrated biotechnology company, researches, develops, manufactures, and sells pharmaceuticals in the therapeutic areas of haematology, immunology, and genetic and metabolic diseases in Europe, North America, and internationally.

SWOBY key facts

Ticker symbol

SWOBY

Market tier

Pink

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Headquarters

Stockholm, Sweden

Country of incorporation

SE

Estimated market cap

$7.98B (as of Apr 15, 2025)

Shares outstanding

295,604,246

Reporting standard

International Reporting: Nasdaq OMX Nordic Exchange Stockholm

Audit status

Audited

Fiscal year end

12/31

Swedish Orphan Biovitrum AB leadership

• Geoffrey McDonough — CEO
• Annika Muskantor — CFO
• Asa Stenqvist — VP, Investor Rel., VP, Corp. Comm.

Explore more: Drug Manufacturers - Specialty & Generic stocks · Healthcare sector · Pink stocks · OTC stocks starting with S